ESTRO 2023 - Abstract Book

S840

Tuesday 16 May 2023

ESTRO 2023

SP-1017 Proton arc therapy: Rationale and current status A. Mazal Spain

Abstract not available

SP-1018 Report from 2022 ESTRO Physics Workshop: How to progress from the concept to clinical reality? S. Mein 1 1 Heidelberg Ion-beam Therapy Center (HIT), German Cancer Research Center (DKFZ), Heidelberg, Germany Abstract Text The first international workshop dedicated to particle arc therapy (PAT) took place on 7-8 October 2022 in Lisbon, Portugal. The event was attended by 42 participants from Europe, Asia and North America, and five vendors (IBA, IBA dosimetry, RaySearch, Elekta and LEO Cancer Care). The purpose of this workshop was as follows: • to connect clinical scientists, researchers and industry members interested in the development and translation of PAT; • to investigate and discuss the physics, radiobiology and clinical aspects of arc delivery that uses protons, carbon ions and other charged particle beams; and, • to establish an international expert group to outline the status, challenges and future directions. In this talk, a summary from the 2022 ESTRO physics workshop, "Particle arc therapy: from concept to clinical reality" will be presented.

SP-1019 Arc therapy or FLASH - Which road to take? T. Lomax Switzerland

Abstract not available

Symposium: Advances in communication technologies within radiotherapy

SP-1021 Innovations in advocating radiotherapy D. Kok 1 , K. Pope 1 1 Peter MacCallum Cancer Centre, Radiation Oncology, Melbourne, Australia

Abstract Text Despite radiation therapy being a safe and highly effective treatment for a broad range of cancers its underutilisation remains relatively widespread. Addressing the knowledge and awareness deficits that have led to this requires both improved education and greater advocacy about radiation therapy. Here we will present a framework to better understand how education and advocacy overlap. We will review some of the latest innovations in the communication and education space – including both technical and theoretical advances – and discuss practical ways that they can be applied by everyday practitioners to improve education and awareness of radiation therapy in their own contexts. We will also discuss the ways in which interdisciplinary collaboration can further enhance the effectiveness of these approaches.

SP-1022 Patient feedback using apps P. Cornacchione Italy

Abstract not available

SP-1023 RTT involvement in digital Intelligence for patient reported outcomes J. Javor 1 1 Princess Margaret Cancer Centre, PROP, Toronto, Canada

Abstract Text Radiation therapy (RT) can be associated with toxicity that can impact patient’s quality of life (QOL). Unlike standard toxicity reporting methods, patient reported outcomes (PROs) are reported directly by the patient, without input from clinicians who are known to under-report side effects compared to patients. PROs allow health care providers to assess the impact of cancer and its treatment side effects on patients, facilitate communication between the patient and the health care team, improve quality of life of cancer patients, and evaluate the effectiveness of treatments and interventions. However, there are challenges with traditional capturing of PRO measures, including under-reporting of symptoms by patients, lack of clinician time to view and act upon PROs and patient recall bias. Several studies have found Radiation Therapist (RTT)-led monitoring of PROs is feasible, safe and improves patient experiences. RTTs are in a unique position within the patient’s circle of care as they interact with the patient daily and thus form a connection with the patient. One study found that the patient-provider relationship has the largest influence on overall patient satisfaction and the patient’s relationship with their RTT had a significant effect on how patients perceived their experience. Another study suggests RTT led treatment reviews is advantageous to patients because they are in close contact with the RTTs, and have built a stronger relationship, allowing easier communication. RTTs collect PROs as standard of care during many points in the patient’s treatment journey: Advanced Practice RTTs collect ESAS scores in review and post-treatment follow up appointments, treatment unit RTTs document side effects of treatment regularly, a clinical trialist RTT is responsible for collecting PROs required for various studies.